Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in Relapsed or Refractory Inflammatory Breast Cancer
NCT00105950Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2005
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of lapatinib in inflammatory breast cancer (IBC), sponsored by GSK. Started Mar 2005; status: completed.
02
Drugs
lapatinib
03
Conditions
inflammatory breast cancer (IBC)
Beyond the preview
Go deeper on NCT00105950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00105950.